The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•13 April 2026•

1 min read

Nuvation Bio Insider Sells 79% of Direct Stake in $904,000 Transaction

Key Facts

1An insider (Wentworth) sold 200,000 Class A shares of Nuvation Bio.

2The total transaction value was $904,000 at an average price of $4.52 per share.

3The sale represents 79.0% of the insider's direct holdings, reducing their stake from 253,000 to 53,000 shares.

An insider at Nuvation Bio (NUVB), identified as Wentworth, has significantly reduced their direct position in the company through a recent share sale. The transaction involved the liquidation of 200,000 Class A shares at an average price of $4.52 per share. The total value of the sale reached approximately $904,000, marking a notable exit for the individual. Following this move, the insider's direct holdings dropped from 253,000 to just 53,000 shares, representing a substantial 79% reduction in their ownership interest. While insider sales can occur for various personal reasons, investors often view such large percentage liquidations as a cautious signal regarding the company's near-term valuation. This activity in the biotech sector is particularly sensitive as it may influence broader market sentiment toward NUVB equities.